Aslam Abbasi Akhtar1,2, Samuel Sances1,2, Robert Barrett1,3, Joshua J Breunig1,2,4,5. 1. Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048. 2. Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048. 3. F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048. 4. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048. 5. Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA, 90095, USA.
Abstract
PURPOSE OF REVIEW: The modeling of biological processes in vitro provides an important tool to better understand mechanisms of development and disease, allowing for the rapid testing of therapeutics. However, a critical constraint in traditional monolayer culture systems is the absence of the multicellularity, spatial organization, and overall microenvironment present in vivo. This limitation has resulted in numerous therapeutics showing efficacy in vitro, but failing in patient trials. In this review, we discuss several organoid and "organ-on-a-chip" systems with particular regard to the modeling of neurological diseases and gastrointestinal disorders. RECENT FINDINGS: Recently, the in vitro generation of multicellular organ-like structures, coined organoids, has allowed the modeling of human development, tissue architecture, and disease with human-specific pathophysiology. Additionally, microfluidic "organ-on-a-chip" technologies add another level of physiological mimicry by allowing biological mediums to be shuttled through 3D cultures. SUMMARY: Organoids and organ-chips are rapidly evolving in vitro platforms which hold great promise for the modeling of development and disease.
PURPOSE OF REVIEW: The modeling of biological processes in vitro provides an important tool to better understand mechanisms of development and disease, allowing for the rapid testing of therapeutics. However, a critical constraint in traditional monolayer culture systems is the absence of the multicellularity, spatial organization, and overall microenvironment present in vivo. This limitation has resulted in numerous therapeutics showing efficacy in vitro, but failing in patient trials. In this review, we discuss several organoid and "organ-on-a-chip" systems with particular regard to the modeling of neurological diseases and gastrointestinal disorders. RECENT FINDINGS: Recently, the in vitro generation of multicellular organ-like structures, coined organoids, has allowed the modeling of human development, tissue architecture, and disease with human-specific pathophysiology. Additionally, microfluidic "organ-on-a-chip" technologies add another level of physiological mimicry by allowing biological mediums to be shuttled through 3D cultures. SUMMARY: Organoids and organ-chips are rapidly evolving in vitro platforms which hold great promise for the modeling of development and disease.
Entities:
Keywords:
BBB-chip; Organoid; cerebral organoids; disease modeling; gut organoids; microfluidics; organ-on-a-chip; personalized medicine
Authors: M Groszer; R Erickson; D D Scripture-Adams; R Lesche; A Trumpp; J A Zack; H I Kornblum; X Liu; H Wu Journal: Science Date: 2001-11-01 Impact factor: 47.728
Authors: H Bart van der Worp; David W Howells; Emily S Sena; Michelle J Porritt; Sarah Rewell; Victoria O'Collins; Malcolm R Macleod Journal: PLoS Med Date: 2010-03-30 Impact factor: 11.069
Authors: Jason R Spence; Christopher N Mayhew; Scott A Rankin; Matthew F Kuhar; Jefferson E Vallance; Kathryn Tolle; Elizabeth E Hoskins; Vladimir V Kalinichenko; Susanne I Wells; Aaron M Zorn; Noah F Shroyer; James M Wells Journal: Nature Date: 2010-12-12 Impact factor: 49.962
Authors: Mao Ye; Henry M Sanchez; Margot Hultz; Zhen Yang; Max Bogorad; Andrew D Wong; Peter C Searson Journal: Sci Rep Date: 2014-04-15 Impact factor: 4.379